Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhancing CAR Macrophage Efferocytosis Via Surface Engineered Lipid Nanoparticles Targeting LXR Signaling
Skylar T. Chuang, Joshua B. Stein, Sarah Nevins, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Open Access | Times Cited: 22

Showing 22 citing articles:

Macrophage plasticity: signaling pathways, tissue repair, and regeneration
Lingfeng Yan, Jue Wang, Xin Cai, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 28
CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond
Jialin Lu, Yuqing Ma, Q. Quentin Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 13
The next frontier in immunotherapy: potential and challenges of CAR-macrophages
Jing Li, Ping Chen, Wenxue Ma
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Exploring CAR-macrophages in non-tumor diseases: Therapeutic potential beyond cancer
Yizhao Chen, Qianling Xin, Mengjuan Zhu, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Mitochondrial Dynamics and Metabolism in Macrophages for Cardiovascular Disease: a review
Yi-lang Zhong, Chenqin Xu, Ji Li, et al.
Phytomedicine (2025) Vol. 140, pp. 156620-156620
Closed Access | Times Cited: 1
Human CSPG4-targeting CAR-macrophages inhibit melanoma growth
Daniel Greiner, Qian Xue, Trinity Q Alaka’i Waddell, et al.
Oncogene (2025)
Open Access | Times Cited: 1
Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?
Daisy Bhatia, Riccardo Dolcetti, Roberta Mazzieri
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
The Atherosclerotic Plaque Microenvironment as a Therapeutic Target
Rajan Pandit, Arif Yurdagul
Current Atherosclerosis Reports (2025) Vol. 27, Iss. 1
Open Access | Times Cited: 1
Silencing of SIRPα enhances the antitumor efficacy of CAR-M in solid tumors
Han Zhang, Yi Huo, Wenjing Zheng, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 11, pp. 1335-1349
Open Access | Times Cited: 5
The efferocytosis dilemma: how neutrophil extracellular traps and PI3K/Rac1 complicate diabetic wound healing
Yulin Xie, Jiaman Yang, He Zhu, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Microneedles Loaded with Nitric-Oxide Driven Nanomotors Improve Force-Induced Efferocytosis Impairment and Sterile Inflammation by Revitalizing Macrophage Energy Metabolism
Hao Tan, Shan Wang, Xinyi He, et al.
ACS Nano (2025)
Closed Access
Advances in the treatment of atherosclerotic plaque based on nanomaterials
Pengyu Wang, Weiwei Chen, Jingfeng Zhang, et al.
Nanomedicine (2025), pp. 1-13
Closed Access
Stimuli-Responsive Nanomedicines for the Treatment of Non-cancer Related Inflammatory Diseases
Jingjing Yang, Anne des Rieux, Alessio Malfanti
ACS Nano (2025)
Open Access
Clusterin ameliorates diabetic atherosclerosis by suppressing macrophage pyroptosis and activation
Lingling Xuan, Lulu Ren, Xin Kang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Targeted lipid nanoparticles distributed in hydrogel treat osteoarthritis by modulating cholesterol metabolism and promoting endogenous cartilage regeneration
Zhibo Zhao, Peng Wang, Ziyang Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Biomaterial-mediated intracellular control of macrophages for cell therapy in pro-inflammatory and pro-fibrotic conditions
Tina Tylek, Joanna Wong, Andrew E. Vaughan, et al.
Biomaterials (2024) Vol. 308, pp. 122545-122545
Open Access | Times Cited: 1
CSPG4-targeting CAR-macrophages inhibit melanoma growth
Daniel Greiner, Qian Xue, Trinity Q Alaka’i Waddell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Nano Delivery System for Atherosclerosis
Rong Zhang, Xuan He, T. Y. Fan, et al.
Journal of Functional Biomaterials (2024) Vol. 16, Iss. 1, pp. 2-2
Open Access | Times Cited: 1
A Dual-Fluorescence Assay for Gene Delivery Vehicle Screening in Macrophages with an Inflammation-Inducible Reporter Construct
Allie Ivy, Shelby N. Bess, Shilpi Agrawal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Shedding new light on atherosclerosis therapeutics: Nanomedicines targeting atherosclerotic immune microenvironment
Zhiyue Wang, Jie Sheng, Guangming Lu, et al.
Deleted Journal (2024) Vol. 1, Iss. 3, pp. 100043-100043
Open Access
Engineered macrophages: an “Intelligent Repair” cellular machine for heart injury
Zhuo Zhang, Hong Du, Weijie Gao, et al.
Cell Regeneration (2024) Vol. 13, Iss. 1
Open Access
Beyond cancer: The potential application of CD47-based therapy in non-cancer diseases
Wei-Qing Deng, Zi-Han Ye, Zhenghai Tang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 15, Iss. 2, pp. 757-791
Open Access
Page 1

Scroll to top